Profile data is unavailable for this security.
About the company
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
- Revenue in CHF (TTM)4.02bn
- Net income in CHF192.40m
- Incorporated2017
- Employees6.13k
- LocationGalenica AGUntermattweg 8BERN 3027SwitzerlandCHE
- Phone+41 588528111
- Fax+41 588528112
- Websitehttps://www.galenica.com/
Mergers & acquisitions
| Acquired company | GALE:SWX since announced | Transaction value |
|---|---|---|
| Puravita AG | 8.52% | -- |
| Diagnostics Group GmbH | 16.06% | -- |
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 31 Dec 2024 | 5.49m | 10.98% |
| Alecta Pension Insurance Mutualas of 31 Dec 2024 | 2.00m | 4.00% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 1.96m | 3.93% |
| Z�rcher Kantonalbank (Investment Management)as of 30 Jan 2026 | 1.46m | 2.92% |
| Vontobel Asset Management AGas of 31 Jan 2026 | 1.15m | 2.31% |
| BlackRock Asset Management Deutschland AGas of 06 Feb 2026 | 952.66k | 1.91% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 916.27k | 1.83% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 844.62k | 1.69% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 735.40k | 1.47% |
| Pictet Asset Management SAas of 31 Oct 2025 | 731.14k | 1.46% |
